Your browser doesn't support javascript.
loading
ERRγ agonist under mechanical stretching manifests hypertrophic cardiomyopathy phenotypes of engineered cardiac tissue through maturation.
Fujiwara, Yuya; Miki, Kenji; Deguchi, Kohei; Naka, Yuki; Sasaki, Masako; Sakoda, Ayaka; Narita, Megumi; Imaichi, Sachiko; Sugo, Tsukasa; Funakoshi, Shunsuke; Nishimoto, Tomoyuki; Imahashi, Kenichi; Yoshida, Yoshinori.
Afiliación
  • Fujiwara Y; Center for iPS Cells Research and Application, Kyoto University, Kyoto, Japan; Takeda-CiRA Joint Program, Fujisawa, Japan.
  • Miki K; Center for iPS Cells Research and Application, Kyoto University, Kyoto, Japan; Center for Organ Engineering, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA; Department of Surgery, Harvard Medical School, Boston, MA, USA. Electronic address: kenjimiki.prime@osaka-u.ac.jp.
  • Deguchi K; Takeda-CiRA Joint Program, Fujisawa, Japan; T-CiRA Discovery, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
  • Naka Y; Center for iPS Cells Research and Application, Kyoto University, Kyoto, Japan; Takeda-CiRA Joint Program, Fujisawa, Japan.
  • Sasaki M; Center for iPS Cells Research and Application, Kyoto University, Kyoto, Japan; Takeda-CiRA Joint Program, Fujisawa, Japan.
  • Sakoda A; Takeda-CiRA Joint Program, Fujisawa, Japan; T-CiRA Discovery, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
  • Narita M; Center for iPS Cells Research and Application, Kyoto University, Kyoto, Japan.
  • Imaichi S; Pharmaceutical Science, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
  • Sugo T; GenAhead Bio Inc., Fujisawa, Japan.
  • Funakoshi S; Center for iPS Cells Research and Application, Kyoto University, Kyoto, Japan; Takeda-CiRA Joint Program, Fujisawa, Japan.
  • Nishimoto T; Orizuru therapeutic Inc., Fujisawa, Japan.
  • Imahashi K; Takeda-CiRA Joint Program, Fujisawa, Japan; T-CiRA Discovery, Takeda Pharmaceutical Company Limited, Fujisawa, Japan.
  • Yoshida Y; Center for iPS Cells Research and Application, Kyoto University, Kyoto, Japan; Takeda-CiRA Joint Program, Fujisawa, Japan. Electronic address: yoshinor@cira.kyoto-u.ac.jp.
Stem Cell Reports ; 18(11): 2108-2122, 2023 11 14.
Article en En | MEDLINE | ID: mdl-37802074
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiomiopatía Hipertrófica / Células Madre Pluripotentes Inducidas Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Stem Cell Reports Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cardiomiopatía Hipertrófica / Células Madre Pluripotentes Inducidas Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Stem Cell Reports Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos